Heron Therapeutics Inc (HRTX)

R&D Expenses

$2.70M

Quarterly · Period ending: · USD

HRTX logo

HRTX R&D Expenses

Latest reported$2.70M
HRTX Quarterly R&D Expenses ($0.00 → $2.70M)
High-resolution chart · PNG

HRTX r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
2,702,000
2,385,000
3,746,000
3,470,000
2,934,000
2,279,000
3,178,000
4,465,000
4,432,000
4,608,000
10,950,000
13,558,000
13,210,000
8,836,000
11,057,000
25,545,000
28,834,000
42,070,000
28,877,000
28,595,000
35,233,000
38,116,000
44,453,000
49,182,000
44,004,000
36,894,000
48,277,000
34,708,000
41,425,000
42,972,000
39,891,000
30,421,000
30,159,000
39,561,000
47,757,000
28,844,000
28,597,000
33,384,000
29,505,000
30,242,000
27,286,000
16,092,000
16,263,000
14,241,000
16,175,000
14,504,000
14,195,000
14,731,000
14,427,000
11,771,000
9,592,000
6,216,000
10,531,000
6,772,000
5,023,000
3,626,000
3,067,000
3,329,000
2,855,000
2,929,000
1,282,000
1,141,000
1,502,000
1,541,000
1,890,000
2,331,000
1,420,000
1,418,000
2,908,000
2,050,000
2,760,000
5,069,000
5,538,000
6,140,000
6,020,000
4,595,000
3,763,000
4,987,000
4,793,000
3,118,000
3,856,000
3,469,000
3,094,000
2,306,000
3,078,000
1,822,000
2,840,000
2,522,000
2,905,000
3,035,000
2,269,000
1,854,000
2,335,000
2,202,000
1,456,000
1,874,000
1,872,000
1,497,000
2,439,000
1,987,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.